A Screening Study To Assess The Cognition Status in Healthy Volunteers
Status: | Completed |
---|---|
Conditions: | Healthy Studies |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - 65 |
Updated: | 8/3/2016 |
Start Date: | August 2013 |
End Date: | July 2014 |
MULTI-CENTER COGNITION ASSESSMENT IN HEALTHY SUBJECTS TO COLLECT REFERENCE DATA FOR COMPARISON TO PATIENTS WITH DEPRESSION
This multi-center screening study will conduct a cognition assessment to collect reference
data for comparison to patients with depression in healthy volunteers. Data will be
collected for 6 weeks.
data for comparison to patients with depression in healthy volunteers. Data will be
collected for 6 weeks.
Inclusion Criteria:
- Healthy volunteers, 18 to 65 years of age, inclusive
- Healthy volunteers with a stable chronic disease that is not associated with
cognitive deficits (e.g. asthma) and does not require any treatment known to affect
cognition have to be discussed with the medical monitor before enrollment
- A body mass index between 18 to 30 kg/m2 inclusive
- Able to participate and willing to give written informed consent and to comply with
the study restrictions
- At least second generation resident in the country of origin
Exclusion Criteria:
- Current or past history of a psychiatric disorder
- Family history of psychiatric disorders
- Suspicion or evidence of regular consumption of drugs of abuse or a positive drug
test at the screening visit
- Acute or chronic disorder which is not stable or may affect cognition or needs
treatment affecting cognition
- Change of smoking behavior or smoking cessation therapy within 30 days before
screening visit
- Positive result on hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) 1
and 2
- Systolic blood pressure greater than 140 or less than 90 mm Hg, and diastolic blood
pressure greater than 100 or less than 50 mm Hg
- Resting Pulse Rate greater than 100 or less than 45 beats per minute
- Clinically significant abnormalities in laboratory test results or in ECG assessment
at screening visit
- Participation in an investigational drug study within 1 month prior to baseline
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials